This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...
A new treatment is now available for people who have certain Parkinson’s Disease symptoms including medication-resistant ...
The latest update is out from Serina Therapeutics ( (SER) ).
AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...
Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...